Nearly 30 million
people have died of AIDS, or complications related to the disease since the
beginning of the epidemic. In 2010, 1.8 million people died of AIDS worldwide, a
25 percent decrease since 2005, thanks to effective medications and access to
treatment. Yet HIV/AIDS still is the single leading cause of death globally.
At the end of 2010,
an estimated 34 million people [31.6 million–35.2 million] were living with HIV
worldwide, up 17% from 2001. This reflects the continued large number of new HIV
infections and a significant expansion of access to antiretroviral therapy,
which has helped reduce AIDS-related deaths, especially in more recent years.
Genetic research indicates that HIV originated in west-central Africa
during the late nineteenth or early twentieth century. AIDS was first
recognized by the U. S. Centers for Disease Control and Prevention in 1981
and its cause, HIV, identified in the early 1980s.
Although treatments for HIV/AIDS can slow the course of the disease, there
is no known cure or HIV vaccine. Antiretroviral treatment reduces both the
deaths and new infections from HIV/AIDS, but these drugs are expensive and
the medications are not available in all countries
The number of people dying of AIDS-related causes fell to 1.8 million [1.6
million–1.9 million] in 2010, down from a peak of 2.2 million [2.1 million–2.5
million] in the mid-2000s. A total of 2.5 million deaths have been averted in
low- and middle-income countries since 1995 due to antiretroviral therapy being
introduced, according to new calculations by UNAIDS. Much of that success has
come in the past two years when rapid scale-up of access to treatment occurred;
in 2010 alone, 700 000 AIDSrelated deaths were averted. The proportion of women
living with HIV has remained stable at 50% globally, although women are more
affected in sub-Saharan Africa (59% of all people living with HIV) and the
There were 2.7 million [2.4 million–2.9 million] new HIV infections in 2010,
including an estimated 390 000 [340 000–450 000] among children. This was 15%
less than in 2001, and 21% below the number of new infections at the peak of the
epidemic in 1997. The number of people becoming infected with HIV is continuing
to fall, in some countries more rapidly than others. HIV incidence has fallen in
33 countries, 22 of them in sub-Saharan Africa, the region most affected by the
Sub-Saharan Africa remains the region most heavily affected by HIV. In 2010,
about 68% of all people living with HIV resided in sub-Saharan Africa, a region
with only 12% of the global population. Sub-Saharan Africa also accounted for
70% of new HIV infections in 2010, although there was a notable decline in the
regional rate of new infections. The epidemic continues to be most severe in
southern Africa, with South Africa having more people living with HIV (an
estimated 5.6 million) than any other country in the world.
Almost half of the deaths from AIDS-related illnesses in 2010 occurred in
southern Africa. AIDS has claimed at least one million lives annually in sub-
Saharan Africa since 1998. Since then, however, AIDS-related deaths have
steadily decreased, as free antiretroviral therapy has become more widely
available in the region.
The total number of new HIV infections in sub-Saharan Africa has dropped by more
than 26%, down to 1.9 million [1.7 million–2.1 million] from the estimated 2.6
million [2.4 million–2.8 million] at the height of the epidemic in 1997. In 22
sub-Saharan countries, research shows HIV incidence declined by more than 25%
between 2001 and 2009. This includes some of the world’s largest epidemics in
Ethiopia, Nigeria, South Africa, Zambia and Zimbabwe. The annual HIV incidence
in South Africa, though still high, dropped by a third between 2001 and 2009
from 2.4% [2.1%–2.6%] to 1.5% [1.3%–1.8%]. Similarly, the epidemics in Botswana,
Namibia and Zambia appear to be declining. The epidemics in Lesotho, Mozambique
and Swaziland seem to be levelling off, albeit at unacceptably high levels.
The Caribbean has the second highest regional HIV prevalence after sub- Saharan
Africa, although the epidemic has slowed considerably since the mid-1990s.
In the Caribbean region, new HIV infections were reduced by a third from 2001
levels. HIV incidence has decreased by an estimated 25% in the Dominican
Republic and Jamaica since 2001, while in Haiti it has declined by about 12%.
Slowing HIV incidence and increasing access to HIV prevention services for
pregnant women have led to a steep decline in the number of children newly
infected with HIV and in AIDS-related deaths among children.
Unprotected sex is the primary mode of transmission in the Caribbean. The number
of people living with HIV has also declined slightly since the early 2000s.
Increased access to antiretroviral therapy has led to a considerable drop in
mortality associated with AIDS.
Although the rate of HIV prevalence is substantially lower in Asia than in some
other regions, the absolute size of the Asian population means it is the second
largest grouping of people living with HIV. In South and South-East Asia, the
estimated 270 000 [230 000–340 000] new HIV infections in 2010 was 40% less than
at the epidemic’s peak in 1996. In India, the country with the largest number of
people living with HIV in the region, new HIV infections fell by 56%. The
prevalence of HIV among key populations at higher risk of infection – notably
sex workers, people who inject drugs and men who have sex with men – is high in
several Asian countries although over time, the virus is spreading to other
populations. The overall trends in this region hide important variations in the
epidemics, both between and within countries. In many Asian countries, national
epidemics are concentrated in relatively few provinces. In China, for example,
five provinces account for 53% of the people living with HIV1, while a
disproportionately large share of Indonesia’s burden is found in its Papua and
West Papua provinces.
Eastern Europe and Central Asia
In Eastern Europe and Central Asia, there was a 250% increase in the number of
people living with HIV from 2001 to 2010. The Russian Federation and Ukraine
account for almost 90% of the Eastern Europe and Central Asia region’s epidemic.
Injecting drug use remains the leading cause of HIV infection in this region,
although considerable transmission also occurs to the sexual partners of people
who inject drugs. There is little indication that the epidemic has stabilized in
the region, with new HIV infections and AIDS-related deaths continuing to
increase. After slowing in the early 2000s, HIV incidence in Eastern Europe and
Central Asia has been accelerating again since 2008. Unlike most other regions,
AIDS-related deaths continue to rise in Eastern Europe and Central Asia. 250% In
Eastern Europe and Central Asia, the number of people living with HIV rose 250%
from 2001 to 2010.
Middle-East and North Africa
HIV-related trends in the Middle East and North Africa vary, as incidence,
prevalence, and AIDS-related deaths are on the rise in some countries, while in
others the epidemic is stable. Generally, HIV prevalence in the region is low,
except in Djibouti and Southern Sudan, where the epidemic is becoming
The HIV epidemics in Latin America are generally stable. A steady decrease in
new annual HIV infections since 1996 levelled off in the early 2000s and has
remained steady since then at 100 000 [73 000–135 000] each year. The total
number of people living with HIV in this region continues to grow. That increase
is partly attributable to the increase in people living with HIV who receive
antiretroviral therapy, which has helped reduce the number of annual
AIDS-related deaths. More than one third (36%) of adults living with HIV in this
region in 2010 were women. The number of children younger than 15 living with
HIV in this region has declined. There was a considerable decrease in new HIV
infections and AIDS-related deaths among children between 2001 and 2010.
The number of annual new HIV infections in Oceania increased slowly until the
early 2000s, and then declined. The number of people living with HIV in this
region reached an estimated 54 000 [48 000–62 000] at the end of 2010, about 34%
more than the estimate for 2001. AIDS-related mortality has decreased
North America, and Western and Central Europe
The HIV epidemic in North America and Western and Central Europe remains
stubbornly steady, despite universal access to treatment, care and support and
widespread awareness of the epidemic and the causes of HIV infection. HIV
incidence has changed little since 2004. The total number of people living with
HIV in North America and Western and Central Europe reached an estimated 2.2
million [1.9 million–2.7 million] in 2010, about one third (34%) more than in
2001. More than half (about 1.2 million) of the people with HIV in this region
live in the United States of America. The rising number of people living with
HIV reflects the wide-scale availability of antiretroviral therapy, especially
in the countries with the largest epidemics, which has significantly reduced
AIDS-related mortality. The number of AIDS-related deaths has varied little
since 2000, despite the 34% increase in the number of people living with HIV.
Recent trends vary across the region. Rates of diagnosed HIV cases doubled
between 2000 and 2009 in Bulgaria, Czech Republic, Hungary, Lithuania, Slovakia
and Slovenia and increased by more than 50% in the United Kingdom. On the other
hand, new HIV diagnoses decreased by more than 20% in Latvia, Portugal and
United States Aids Statistics
In 2009, the estimated
number of diagnoses of HIV infection in the 40 states and 5 U.S.
dependent areas with confidential name-based HIV infection reporting was
42,959. Of these, 42,011 were in the 40 states and 948
were in the 5 dependent areas. In the 40 states, diagnoses of HIV infection
among adults and adolescents totaled 41,845 with 31,872
diagnoses in males and 9,973 diagnoses in females, Among
children under age 13 years, there were an estimated 166 diagnoses of
HIV infection in 2009.
What is HIV?
HIV stands for 'human immunodeficiency virus'. HIV is a virus (of the type
retrovirus) that infects cells of the human immune system (mainly CD4 positive T
and macrophages—key components of the cellular immune system), and destroys or
impairs their function. Infection with this virus results in the progressive
the immune system, leading to 'immune deficiency'.
The immune system is considered deficient when it can no longer fulfill its role
off infections and diseases. Immunodeficient people are more susceptible to a
range of infections, most of which are rare among people without immune
Infections associated with severe immunodeficiency are known as 'opportunistic
infections', because they take advantage of a weakened immune system.
What is AIDS?
AIDS stands for 'acquired immunodeficiency syndrome' and is a surveillance
based on signs, symptoms, infections, and cancers associated with the deficiency
immune system that stems from infection with HIV.
What are the
symptoms of HIV?
Most people infected with HIV do not know that they have become infected,
they do not feel ill immediately after infection. However, some people at the
seroconversion develop “Acute retroviral syndrome” which is a glandular
illness with fever, rash, joint pains and enlarged lymph nodes.
Seroconversion refers to the development of antibodies to HIV and usually takes
between 1 and 6 weeks after HIV infection has happened.
Whether or not HIV infection causes initial symptoms, an HIV-infected person is
infectious during this initial period and can transmit the virus to another
person. The only
way to determine whether HIV is present in a person's body is by testing for HIV
antibodies or for HIV itself.
After HIV has caused progressive deterioration of the immune system, increased
susceptibility to infections may lead to symptoms.
There is clear evidence that AIDS is caused by a virus called HIV, which is
HIV is a virus. Illnesses caused by a virus cannot be cured by antibiotics.
(Although medicines may help to reduce the symptoms) People who have a virus -
such as a cold- usually get better after a few days or weeks because the white
blood cells of the immune system - which are responsible for fighting diseases -
successfully overcomes them.
When a person is infected with HIV the immune system tries to fight off the
virus and does make some antibodies, but these antibodies are not able to defeat
The person is said to be HIV Positive. Many people do not feel ill at all when
they are first infected. They may have no symptoms for a long time. They have
not yet got AIDS.
HIV acts by gradually destroying the immune system of the infected person. After
about 5 to 10 years (although much earlier in a minority of cases) the immune
system becomes so weak - or 'deficient'- that it cannot fight off infections as
it used to.
Eventually the infected person may lose weight and become ill with diseases like
persistent severe diarrhea, fever, or pneumonia, or skin cancer. He or she has
now developed AIDS.
At the moment, in spite of much research, there is no cure for HIV or for AIDS
and so, sadly, it is almost certain that people diagnosed with AIDS will die.
These are the most
common ways that HIV is transmitted from one person to another:
by having sexual
contact with an HIV-infected person
needles or injection equipment with an injection drug user who is infected
HIV-infected women to babies before or during birth, or through
breast-feeding after birth
HIV also can be transmitted through
transfusions of infected blood or blood clotting factors.
HIV is not
transmitted by day-to-day contact in the workplace, schools, or social settings.
HIV is not transmitted through shaking hands, hugging, or a casual kiss. You
cannot become infected from a toilet seat, a drinking fountain, a door knob,
dishes, drinking glasses, food, or pets.
The Red Ribbon is an international symbol of AIDS awareness that is worn by
people all year round and particularly around world AIDS day to demonstrate care
and concern about HIV and AIDS, and to remind others of the need for their
support and commitment. The red ribbon started as a "grass roots" effort, and as
a result there is no official red ribbon, and many people make their own. To
make your own ribbons, get some ordinary red ribbon, about 1.5 cms wide and cut
it into strips about 15 cms long. Then fold at the top into an inverted "V"
shape and put a safety pin through the center which you use to attach the ribbon
to your clothing.
AIDS/HIV Science Facts
What is a virus?
organism that infects another organism's cells and can cause harm. Viruses
can be composed of DNA or RNA genetic material.
What are some
examples of viruses?
measles, chicken pox, flu, hepatitis, herpes, polio, …
What is a
A virus that stores
its genetic information as RNA, but translates back to DNA before replicating.
This process is the reverse of the usual process and requires a special viral
enzyme called Reverse Transcriptase. HIV is one example of a retrovirus.
What is the
structure of HIV?
The structure of HIV
is like most other viruses. It consists of:
An envelope, which
provides structure to the virus and houses the nucleic acid core.
Outer surface glycoproteins, which act as "keys" that can latch onto the outside
of T cells, and help inject the nucleic acid into the cell.
An RNA genome, which contains the information and directions on infecting the
cell, replicating, and performing the actions that eventually destroy the cell.
What is the
The body's defense
against foreign invaders and cancerous cells. It involves B cells that
produce antibodies, T cells that directly attack foreign cells, and phagocytes
that eat up foreign material.
How does HIV
affect the immune system?
HIV infects helper T
cells that display a certain protein, called the CD4 receptor. Once inside
the cell, HIV takes over the cell and the virus replicates. In a couple of
days, the cell dies and the new virus particles go on to infect more helper T
What are the
stages of the disease?
Stage 1 - Primary
HIV infection - lasts a few weeks, flu-like symptoms
Stage 2 - Latent period - may last years, patient has no symptoms
Stage 3 - Symptomatic HIV infection - as more and more T cells are destroyed,
the body becomes overly susceptible to
opportunistic infections and cancers
Stage 4 - AIDS - helper T cell count is <200, patient develops 1 or more
What is an
An illness that
normal people with healthy immune systems can fight off. People with AIDS
cannot fight these infections and will eventually die. Even the common flu
can kill a person with AIDS.
HIV does not survive
well outside of the body. There are many myths about how HIV is passed.
Here are the facts:
You cannot get
HIV through casual contact such as shaking hands or hugging a person with
You cannot get
HIV from using a public telephone, drinking fountain, restroom, swimming
pool, Jacuzzi, or hot tub.
You cannot get
HIV from sharing a drink.
You cannot get
HIV from being coughed or sneezed on by a person with HIV/AIDS.
You cannot get
HIV from giving blood.
You cannot get
HIV from a mosquito bite.
A disease of the body's immune system caused by the human immunodeficiency virus
(HIV). AIDS is characterized by the death of CD4 cells (an important part of the
body's immune system), which leaves the body vulnerable to life-threatening
conditions such as infections and cancers.
Also known as immunoglobulin. A protein produced by the body's immune system
that recognizes and fights infectious organisms and other foreign substances
that enter the body. Each antibody is specific to a particular piece of an
infectious organism or other foreign substance.
Treatment with drugs that inhibit the ability of retroviruses (such as HIV) to
multiply in the body. The antiretroviral therapy recommended for HIV infection
is referred to as highly active antiretroviral therapy (HAART), which uses a
combination of medications to attack HIV at different points in its life cycle.
Also known as helper T cell or CD4 lymphocyte. A type of infection-fighting
white blood cell that carries the CD4 receptor on its surface. CD4 cells
coordinate the immune response, signaling other cells in the immune system to
perform their special functions. The number of CD4 cells in a sample of blood is
an indicator of the health of the immune system. HIV infects and kills CD4
cells, leading to a weakened immune system
CD4 Cell Count
A measurement of the number of CD4 cells in a sample of blood. The CD4 count is
one of the most useful indicators of the health of the immune system and the
progression of HIV/AIDS. A CD4 cell count is used by health care providers to
determine when to begin, interrupt, or halt anti-HIV therapy; when to give
preventive treatment for opportunistic infections; and to measure response to
treatment. A normal CD4 cell count is between 500 and 1,400 cells/mm3 of blood,
but an individual's CD4 count can vary. In HIV-infected individuals, a CD4 count
at or below 200 cells/mm3 is considered an AIDS-defining condition.
A research study that uses human volunteers to answer specific health questions.
Carefully conducted clinical trials are regarded as the fastest and safest way
to find effective treatments for diseases and conditions, as well as other ways
to improve health. Interventional trials use controlled conditions to determine
whether experimental treatments or new ways of using known treatments are safe
and effective. Observational trials gather information about health issues from
groups of people in their natural settings.
Infection with more than one virus, bacterium, or other micro-organism at a
given time. For example, an HIV-infected individual may be co-infected with
hepatitis C virus (HCV) or tuberculosis (TB).
The virus that causes Acquired Immunodeficiency Syndrome (AIDS). HIV is in the
retrovirus family, and two types have been identified: HIV-1 and HIV-2. HIV-1 is
responsible for most HIV infections throughout the world, while HIV-2 is found
primarily in West Africa.
The collection of cells and organs whose role is to protect the body from
foreign invaders. Includes the thymus, spleen, lymph nodes, B and T cells, and
Also known as experimental drug. A drug that has not been approved by the FDA to
treat a particular disease or condition. The safety and effectiveness of an
investigational drug must be tested in clinical trials before the manufacturer
can request FDA approval for a specific use of the drug.
The time period when an infectious organism is in the body but is not producing
any noticeable symptoms. In HIV disease, latency usually occurs in the early
years of infection. Also refers to the period when HIV has integrated its genome
into a cell's DNA but has not yet begun to replicate.
A natural or man-made substance that kills microbes. Researchers are studying
the use of microbicides to prevent the transmission of sexually transmitted
diseases (STDs), including HIV infection.
Illnesses caused by various organisms that occur in people with weakened immune
systems, including people with HIV/AIDS. OIs common in people with AIDS include
Pneumocystis carinii pneumonia; cryptosporidiosis; histoplasmosis;
toxoplasmosis; other parasitic, viral, and fungal infections; and some types of
A type of lymphocyte (disease-fighting white blood cell). The "T" stands for the
thymus, where T cells mature. T cells include CD4 cells and CD8 cells, which are
both critical components of the body's immune system.
Any HIV vaccine used for the treatment of an HIV-infected person. Therapeutic
HIV vaccines are designed to boost an individual's immune response to HIV
infection in order to better control the virus. This therapeutic approach is
currently being tested in clinical trials
A substance that stimulates the body’s immune response in order to prevent or
control an infection. A vaccine is typically made up of some part of a bacteria
or virus that cannot itself cause an infection. Researchers are testing vaccines
both to prevent and treat HIV/AIDS; however, there is currently no vaccine
approved for use outside of clinical trials.
HIV & AIDS Timeline
believe that sometime in the 1930s a form of simian immunodeficiency virus (SIV)
jumped to humans who butchered or ate chimpanzee bush meat in the Democratic
Republic of Congo. The virus becomes HIV-1 the most widespread form found today
• The world’s first
known case of AIDS has been traced to a sample of blood plasma from a man who
died in the Democratic Republic of Congo in 1959
• HIV-2, which is
restricted to West Africa, is thought to have transferred to people from sooty
mangabey monkeys in Guinea-Bissau during the 1960s
• A genetic analysis
of HIV in 2003 suggests that it may have first arrived in the United States in
• During the 1970s
it continues to spread undetected in the US and around the world - the pandemic
• A high prevalence
of both a rare type of skin cancer - Kaposi’s Sarcoma - and pneumonia are found
in young gay men in New York and California, US. These are the first documented
cases of AIDS. By the end of the year 121 people are known to have died from the
• Centers for
Disease Control and Prevention (CDC) scientists, in Atlanta, US, predict that
the immune system disorder affecting gay men is due to an infection. They
establish the term Acquired Immune Deficiency Syndrome (AIDS) and determine that
aside from gay men, other groups at risk are injecting drug users, people of
Haitian origin and haemophiliacs
• By 1982 AIDS had
been detected on five continents
• It is revealed
that a wasting disorder known in Africa as “slim disease” is a form of AIDS
• AIDS epidemics are
developing in Europe: one in gay men who have visited the US, another in people
with links to central Africa
begin into the occurrence of AIDS in Rwanda, Zaire and other African nations
• Using recently
developed techniques, the retrovirus responsible for AIDS is independently
discovered by Luc Montagnier of the Pasteur Institute in Paris, France, and
Robert Gallo of the National Cancer Institute in Washington DC, US. It is later
named the human immunodeficiency virus (HIV)
• Cases of AIDS
passed on through heterosexual intercourse begin to appear
• The first
International AIDS conference is held in Atlanta, US
• Following the
previous year’s discovery of the HIV virus, the first HIV test is licensed by
the US Food and Drug Administration (FDA)
• US blood banks are
screened for the virus
• AZT (zidovudine),
the first antiretroviral drug, becomes available to treat HIV sufferers after a
successful clinical trial. The drug works by blocking the action of HIV's enzyme
reverse transcriptase, stopping the virus from replicating in cells. AZT slows
down the course of AIDS, delaying death
• By 1987, 16,908
people have died from AIDS in the US. In total 71,751 cases of AIDS had been
reported to the World Health Organization (WHO), 47,022 in the US
• Estimating that as
many as 5 to 10 million people could be infected with HIV worldwide, the WHO
launches its Global Programme on AIDS
• WHO declares the
first World AIDS Day on 1 December
• The red ribbon
becomes an international symbol of AIDS awareness
• In the US, AIDS
becomes the leading cause of death for 24 to 44 year old men
• The first
combination drug therapies for HIV are introduced, when the US FDA approves the
use of the ddC, which also blocks reverse transcriptase, alongside AZT. HIV drug
cocktails are more effective and the multi-pronged attacks slow down the
development of drug resistance
• Using AZT to
reduce the transmission of HIV from pregnant women to unborn fetuses is
recommended in the US. A study shows it cuts the rate of maternal transmission
to 8% - in women taking a placebo the rate was 25%
• Over 12 after the
discovery of AIDS, the US government launches its first national media campaign
explicitly promoting condoms
• Saquinavir, a new
type of protease inhibitor drug, becomes available to treat
• HIV. These drugs
result in defective HIV forming, which cannot infect new cells. This new more
powerful drug heralds the start of Highly Active Antiretroviral Therapy (HAART)
- a combination therapy regimen using a “cocktail” of drugs
• One million cases
of AIDS have been reported to the WHO, 19.5 million people have been infected
with HIV since the epidemic began
• The International
AIDS Vaccine Initiative (IAVI) - a non-profit organisation based in New York
City - is set up to speed the search for an HIV vaccine
• 90% of all people
infected with HIV now live in the developing world
• Annual US death
rates from AIDS dramatically fall for the first time, due to the introduction of
• UN announces that
40 million children could have lost one or both parents to AIDS by 2010
• The first
full-scale trial of a vaccine against HIV begins in the US
• Two teams of
researchers begin developing vaccines targeted against the strains of HIV
prevalent in sub-Saharan Africa
• An HIV strain
resistant to all protease inhibitor drugs currently on the market turns up in
San Francisco. Unusual side effects, such as the growth of fatty pads and heart
problems, are occurring in some users of protease inhibitors
• Edward Hooper
releases his book, The River, which accuses doctors who tested a polio
vaccine in 1950s Africa of unintentionally starting the AIDS epidemic. The idea
is rejected in 2001 by a wide group of researchers
• 33 million people
are infected with HIV, and 14 million have died of AIDS worldwide
• AIDS becomes the
fourth biggest killer worldwide
• An Indian company
starts to sell discounted copies of expensive patented AIDS drugs to a medical
charity in Africa. The move forces some pharmaceutical companies to slash prices
• Five million
people are newly infected with AIDS during 2003, the greatest number in one year
since the epidemic began. Three million die from AIDS in the same year
• A vaccine for AIDS
is still years away, warns the IAVI. Less than 3% of all money devoted to AIDS
goes towards developing a vaccine for the disease
• HIV blocking
microbicides go on trial. The vaginal creams may provide a powerful weapon
against the spread of HIV. Animal studies show some prevent infection in up to
75% of cases
• A drug that stops
the HIV virus from stitching itself into human chromosomes is found to fight
AIDS in an animal study. In the face of emerging drug-resistant HIV strains, the
find could offer a new approach
• Around 40 million
people are infected with AIDS worldwide
• A highly resistant
strain of HIV linked to rapid progression to AIDS is identified in New York
marks a quarter century since first AIDS case reported
Annual National Women and Girls HIV/AIDS Awareness Day in the United
Congress reauthorizes the Ryan White CARE Act for the third time
Bush calls on Congress to reauthorize PEPFAR at $30 billion over 5
releases new HIV incidence estimates for the United States, showing
that the U.S. epidemic is worse than previously thought.
Obama launches the Global Health Initiative (GHI), a six-year, $63
billion effort to develop a comprehensive approach to addressing
global health in low and middle income countries, with PEPFAR as a
Administration officially lifts HIV travel and immigration ban by
removing the final regulatory barriers to entry, to take effect in
January 2010. Leads to announcement that the International AIDS
Conference will return to the United States for the first time in more
than 20 years, and be held in be held in Washington, DC in 2012.
Administration releases first comprehensive National HIV/AIDS Strategy
for the United States
marks30 years since first AIDS case reported
Scientist, WHO, UNAIDS, New York Times, The Henry J. Kaiser Family
Foundation, AIDS Action
Information Visit the sites Below
Credit: The United Nations, Aids.gov ,CDC
Data compiled from The
British Antarctic Study, NASA, Environment Canada, UNEP, EPA and
other sources as stated and credited Researched by Charles
Welch-Updated daily This Website is a project of the The Ozooe Hole